4
Changes in Ownership
Dolby Laboratories, Inc. Filed Acc 0001209191-20-008137
EVP & Chief Financial Officer sold 37,900 shares at an average $71.01 ($2,691,358)
- EVP & Chief Financial Officer acquired 37,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHEW LEWIS EVP & Chief Financial Officer | 2020-02-07 | Option exercise | +4,400 | $30.49 | $134,156 | 102,447 | D |
| CHEW LEWIS EVP & Chief Financial Officer | 2020-02-07 | Sale | −4,400 | $70.80 | $311,501 | 98,047 | D |
| CHEW LEWIS EVP & Chief Financial Officer | 2020-02-07 | Option exercise | +33,500 | $37.35 | $1,251,225 | 131,547 | D |
| CHEW LEWIS EVP & Chief Financial Officer | 2020-02-07 | Sale | −33,500 | $71.04 | $2,379,857 | 98,047 | D |
| Derivatives | |||||||
| CHEW LEWIS EVP & Chief Financial Officer | 2020-02-07 | Option exercise · Employee Stock Option (right to buy) | −4,400 | 0 | D | ||
| CHEW LEWIS EVP & Chief Financial Officer | 2020-02-07 | Option exercise · Employee Stock Option (right to buy) | −33,500 | 70,152 | D | ||
| Open-market sales · 37,900 sh · avg $71.01 · $2,691,358 | |||||||
Loading xslF345X03/doc4.xml…